Seven Grand Managers »

Stoke Therapeutics shares owned by Seven Grand Managers

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Seven Grand Managers from 13F filings

Historical chart of Seven Grand Managers investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Seven Grand Managers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Seven Grand Managers

Quarter filed Position value Share count Share price at filing
2024-03-31 $405k 30k 13.50

More positions owned by Seven Grand Managers

Nextracker Class A Com (NXT)
Core & Main Cl A (CNM)
Dominion Resources (D)
Super Micro Computer (SMCI)
Exelon Corporation (EXC)
Arm Holdings Sponsored Adr (ARM)
Ge Healthcare Technologies I Common Stock (GEHC)
Permian Resources Corp Class A Com (PR)
Cava Group Ord (CAVA)
SYNNEX Corporation (SNX)
Terreno Realty Corporation (TRNO)
Keurig Dr Pepper (KDP)
Matador Resources (MTDR)
Dutch Bros Cl A (BROS)
Essential Properties Realty reit (EPRT)

View all positions for Seven Grand Managers

Top funds holding Stoke Therapeutics

Skorpios Trust
Cowen And Company
Lynx1 Capital Management
Redmile Group
Baker Bros. Advisors
Vanguard Group
Goldman Sachs Group
Cormorant Asset Management
Deutsche Bank Aktiengesellschaft
Healthcare Of Ontario Pension Plan Trust Fund
Dimensional Fund Advisors
Charles Schwab Investment Management
Jacobs Levy Equity Management
D. E. Shaw & Co
GSA Capital Partners

View all funds holding Stoke Therapeutics